Joining Forces: Small Companies Approach National GPOs
To attain the same kind of leverage commanded by large competitors such as Johnson & Johnson or Baxter, some smaller firms are beginning to form alliances that will permit them to approach GPOs with bundles of products. The latest such effort: InterMedway Inc., in pulmonary devices.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
BeiGene gets a new chief business executive and there are new CMOs at Cellectar Biopharma, MacroGenics and Reata Pharmaceuticals.
A new EU pilot will help drug regulators and policymakers understand the factors influencing the uneven availability of centrally authorized medicines in the member states.